China SXT Pharmaceuticals (SXTC) Non-Current Assets (2018 - 2026)

China SXT Pharmaceuticals (SXTC) has reported Non-Current Assets for 9 consecutive years, with $244852.0 the latest figure, recorded in Q1 2026.

• Quarterly Non-Current Assets fell 33.29% year-over-year to $244852.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $244852.0 (down 33.29% YoY) and the FY2026 annual result came in at $244852.0, down 33.29% from the prior year.
• Non-Current Assets retreated to $244852.0 in Q1 2026 per SXTC's latest filing, from $310889.0 in the prior quarter.
• Over the last five years, Non-Current Assets for SXTC reached as high as $11.1 million in Q1 2022 and fell as low as $244852.0 in Q1 2026.
• A 5-year average of $5.7 million and a median of $8.9 million in 2024 frame the typical range for Non-Current Assets.
• Annual changes were most pronounced in 2024 — Non-Current Assets soared 724.5% — and 2025, when it tumbled 96.55%.
• Year by year, Non-Current Assets stood at $9.8 million in 2022, then slumped by 88.87% to $1.1 million in 2023, then surged by 724.5% to $9.0 million in 2024, then slumped by 96.55% to $310889.0 in 2025, then declined by 21.24% to $244852.0 in 2026.
• According to Business Quant data, Non-Current Assets over the past three periods registered $244852.0, $310889.0, and $367017.0 for Q1 2026, Q3 2025, and Q1 2025 respectively.